Betaxolol is a cardioselective beta blocking agent commonly used to treat hypertension and elevated intraocular pressure (when administered ophthalmically). A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
- Mechanism
- Curator reviewed
Betaxolol selectively blocks catecholamine stimulation of beta(1)-adrenergic receptors in the heart and vascular smooth muscle. This results in a reduction of heart rate, cardiac output, systolic and diastolic blood pressure, and possibly reflex orthostatic hypotension. Betaxolol can also competitively block beta(2)-adrenergic responses in the bronchial and vascular smooth muscles, causing bronchospasm.
- Primary indication
- For the management of hypertension.Curator reviewed · 3 structured indications
- Formula / weight
- C18H29NO3 · 307.4278 g/mol (avg)
- First approval
- Canada, 1998 · United States, 1989
- Brand names
Resolves to
NWIUTZDMDHAVTP-UHFFFAOYSA-NSMILESCC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Betaxolol, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account